Figure 3From: In vitro the behaviors of metastasis with suppression of VEGF in human bone metastatic LNCaP-derivative C4-2B prostate cancer cell line Suppressed tube formation of human microvessel by conditioned media from C4-2B cells treated with bevacizumab (right) or control IgG (left). Back to article page